Anti Human 217 Position Phosphorylated Tau Protein (p-Tau217) Monoclonal Antibody
Click to zoom in

Have Questions? | Bulk Inquiry?

Anti Human 217 Position Phosphorylated Tau Protein (p-Tau217) Monoclonal Antibody

A50564-100ug
Out of stock In stock
$699.00
$699.00

Anti Human 217 Position Phosphorylated Tau Protein (p-Tau217) Monoclonal Antibody

Anti Human 217 Position Phosphorylated Tau Protein (p-Tau217) Monoclonal Antibody

Clone HI564    Catalog#: A50564

Description: Phosphorylation of Tau proteins is a normal regulatory mechanism, but in neurodegenerative diseases such as Alzheimer’s disease (AD), Tau can become abnormally hyperphosphorylated. This hyperphosphorylation leads to the dissociation of Tau from microtubules, the formation of toxic aggregates known as neurofibrillary tangles, and the disruption of neuronal function. 
The phosphorylation of Tau at threonine 217 (T217) is one of the sites that are often modified in AD and other tauopathies. The phosphorylation at this site is thought to be particularly relevant to the pathogenesis of these diseases. Tau217 is considered a pathological phosphorylation site and has been found to correlate with the degree of cognitive impairment in AD patients.

Isotype:

Mouse IgG

Species reactivity:

Mouse

Production:

Tissue culture

Purification:

Protein A/G

Applications:

ELISA, WB, IFA, IHC, CLIA, LFA, IP

Immunogen: 

Recombinant human p-Tau217 protein

Storage: 

Store at +4°C short term (1-2 weeks). Store at -20°C long term.

Formulation:

PBS, pH 7.4, Filter sterilized. Endotoxin level tests less than 0.06 EU/ug.

Clonality:

Monoclonal

 

Reference: 
1. Lasagna-Reeves, C. A., & Kayed, R. (2012). Astrocytes as targets for the treatment of Alzheimer’s disease. Current Pharmaceutical Design, 18(36), 5891-5896.
2. Mocanu, M. M., & Popescu, B. O. (2018). The role of tau protein in the pathogenesis of Alzheimer’s disease. Journal of Alzheimer’s Disease, 64(3), 677-693.
3. Andreadaki, A., & Vekrellis, K. (2018). Tau-driven pathology in Alzheimer’s disease and related tauopathies: a critical review. Journal of Neurochemistry, 143(5), 595-608.

Intended for research use only. Not for human, therapeutic, or diagnostic applications.
The buyer cannot sell or otherwise transfer this product for Commercial Purposes without written approval of Humimmu LLC.  
Copyright 2024. Humimmu LLC.  All Rights Reserved

Read More
Read Less

Please make sure that you follow below steps:

1/ Add your items of interest to the shopping cart by clicking Add to Cart.

2/ When you've finished shopping, click Check Out .You'll be asked to register if you are new to us.

3/ Fill in required shipping and payment information. We accept Credit Card and Paypal for online orders.

4/ Review your order, and then click Continue to Check Out.

5/ A confirmation email including tracking information of your order will be delivered to you through email within 24 hours. Please note that in case the item you are trying to purchase is not in stock, we will contact you directly to let you know the lead time.

If your company have credit reference sheet, please email (info@humimmu.com) to us, you are allowed to pay within 30 days after confirmation by our financial department.

If you don’t have credit reference sheet, please email (info@humimmu.com) us, and we will provide the Business Account Application Form for you.

Kindly remind that before applying for the payment terms, a full prepayment is required for the first time order from a valued new customer.

The cookie settings on this website are set to 'allow all cookies' to give you the very best experience. Please click Accept Cookies to continue to use the site.

Your cart

×